A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
about
Pathways for aberrant angiogenesis in pancreatic cancerRole of hypoxia and vascular endothelial growth factors in lymphangiogenesisLymphatic Vessels, Inflammation, and Immunity in Skin CancerDevelopment of the mammalian lymphatic vasculatureAngiogenesis in metastatic colorectal cancer and the benefits of targeted therapyLymphatic imaging to assess rheumatoid flare: mechanistic insights and biomarker potentialMicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cellsDoxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasisBlood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.No association of vascular endothelial growth factor-A (VEGF-A) and VEGF-C expression with survival in patients with gastric cancer.Zebrafish ProVEGF-C expression, proteolytic processing and inhibitory effect of unprocessed ProVEGF-C during fin regeneration.Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis.Impact of lymph node micrometastasis in hilar bile duct carcinoma patients.A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinasesVascular endothelial growth factor receptor-2 in breast cancer.The lymphatic system in health and disease.Lymphangiogenesis: a new player in cancer progression.Current views on the function of the lymphatic vasculature in health and diseaseSerum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer.Filariasis and lymphoedema.Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery.CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels.Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.Lymphangiogenesis and hemangiogenesis: potential targets for therapyPrognostic Significance of VEGF-C Expression in Patients with Breast Cancer: A Meta-Analysis.Cardiac lymphatics are heterogeneous in origin and respond to injury.Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis.Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.Tumor lymphangiogenesis as a potential therapeutic target.Risk factors for lymphatic metastasis of malignant bone and soft-tissue tumors: a retrospective cohort study of 242 patients.AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.Hypoxia increases breast cancer cell-induced lymphatic endothelial cell migration.Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesisMT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis.Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissuesInduced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator
P2860
Q24800215-6053D036-7469-432D-9C71-5870AD16E55AQ26745683-6A6F0D08-8DB4-4498-9371-30FFB08AC6B9Q26778332-3C0669D8-D667-4758-8555-760E22D06B78Q26852649-1BDB5580-B39A-4677-AC2E-5540D530D4CFQ26853604-9CBDBA0D-8CED-4F82-A584-8B7795C4E037Q27325628-9B6F8209-D126-498D-8539-E4098FD6ACC7Q28273264-E0625331-319D-4A40-8996-8F908014A26FQ28469047-4BED8478-F77B-412A-8095-59FC83FDB442Q30498120-21BA7688-DD55-4B37-824A-7352BCD6D73AQ33326045-22626484-9DCA-4C07-AD83-70FEDA90B221Q33509896-E1174229-A152-4316-952B-2937B68324CEQ33576258-37E29A88-B32C-4BE3-8008-6C45E8C66BCBQ33631088-5480EC33-51D8-484F-950A-C09B4CA3CAAFQ33651167-E3C19052-E820-4C50-AB57-4CD5AE98D99BQ33651381-499D13AF-B529-4213-8CD7-878B438FF05BQ33868494-9C521E0E-0521-41EE-9D58-8B050B65F65BQ33890319-6B48A146-A669-472B-81E8-A69AAB8B8514Q33912620-A2251335-654D-483A-A367-5023ACADBBC5Q34015299-C4F4ECDE-6AFE-4361-8CD5-D53A0560502FQ34084937-0CB5C0A8-C353-4159-A6A0-8C284F2FDC98Q34164880-52DE196A-A119-41E3-823D-0E1BC0890195Q34577121-23BB188F-6F9E-41B7-8775-78F6BB28AD03Q34612712-449E991C-4F7E-4D4E-B135-1FF5B7540548Q34624074-3FDEA8F1-400C-436C-9C0E-4B2A00A0DD6EQ34683635-B3D3F14F-8319-4FA3-B642-C3EA381A58E7Q35073422-06459DB9-1770-4E4C-999B-23CA63897C9EQ35374781-60B3B8BA-0D6C-4A97-B0AE-4761F908A993Q35575870-CD4269FB-FB6B-44BB-88E6-C883F3D0506FQ35670023-05F15884-27D5-4564-BA65-E44C1BC9EF30Q35690246-33D8A5DE-B542-4F7A-9EB3-2EF618FD7B7BQ35785994-647653CD-0A49-4BCF-83C9-C0B1ACD53498Q35787996-A4D32270-C4AC-48EF-B893-870AD135A9DCQ35838122-5CF03EAB-A2F3-4EF8-9515-117F7BC67AE6Q36152563-D2FD9323-83FC-4F1F-8A94-91A5BB27F3E0Q36460444-A00BF94E-3C17-4E66-BEBA-11571DA68C18Q36528217-48A3C3C0-C5A6-4875-BA75-D7468DD5C9B1Q36610236-3BFAD44D-90FC-445F-9F2A-F472C9A46DE5Q36637462-265C73FB-C328-4358-A1B5-49E95B45F26DQ36642309-D039BD69-0ED3-43DE-B7E1-0032150789F1Q36642949-C240B252-DB46-410D-BDE6-3722F0D51A5A
P2860
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
A novel vascular endothelial g ...... R-2) receptor tyrosine kinases
@en
A novel vascular endothelial g ...... R-2) receptor tyrosine kinases
@nl
type
label
A novel vascular endothelial g ...... R-2) receptor tyrosine kinases
@en
A novel vascular endothelial g ...... R-2) receptor tyrosine kinases
@nl
prefLabel
A novel vascular endothelial g ...... R-2) receptor tyrosine kinases
@en
A novel vascular endothelial g ...... R-2) receptor tyrosine kinases
@nl
P2093
P3181
P356
P1433
P1476
A novel vascular endothelial g ...... R-2) receptor tyrosine kinases
@en
P2093
A Kaipainen
I Lahtinen
K Pajusola
N Kalkkinen
P3181
P356
10.1093/EMBOJ/18.2.363
P407
P577
1996-04-01T00:00:00Z